Combination approaches to target pd-1 signaling in cancer

HIGHLIGHTS

• who: Emily K. Moore from the Division of Rheumatology, Department of Medicine, Columbia University Medical Center, New York, NY, United States have published the research: Combination Approaches to Target PD-1 Signaling in Cancer, in the Journal: (JOURNAL)
• what: This work shows that interfering with the mediators of PD-1 signaling can have a favorable impact on tumor progression, and is a valid therapeutic strategy.
• future: One way to thin out the number of unsuccessful future trials is to strive for stronger pre-clinical evidence of a new target`s promise before bringing . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.